annual accounts payable:
$12.95M-$2.17M(-14.37%)Summary
- As of today (May 27, 2025), FOLD annual accounts payable is $12.95 million, with the most recent change of -$2.17 million (-14.37%) on December 31, 2024.
- During the last 3 years, FOLD annual accounts payable has fallen by -$8.57 million (-39.82%).
- FOLD annual accounts payable is now -40.40% below its all-time high of $21.72 million, reached on December 31, 2019.
Performance
FOLD Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$14.45M+$1.50M(+11.62%)Summary
- As of today (May 27, 2025), FOLD quarterly accounts payable is $14.45 million, with the most recent change of +$1.50 million (+11.62%) on March 31, 2025.
- Over the past year, FOLD quarterly accounts payable has increased by +$5.24 million (+56.91%).
- FOLD quarterly accounts payable is now -82.82% below its all-time high of $84.12 million, reached on June 30, 2019.
Performance
FOLD quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
FOLD Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.4% | +56.9% |
| 3 y3 years | -39.8% | -36.9% |
| 5 y5 years | -40.4% | -11.0% |
FOLD Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -39.8% | at low | -54.9% | +56.9% |
| 5 y | 5-year | -40.4% | at low | -54.9% | +56.9% |
| alltime | all time | -40.4% | +2342.8% | -82.8% | +4175.4% |
FOLD Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $14.45M(+11.6%) |
| Dec 2024 | $12.95M(-14.4%) | $12.95M(-4.0%) |
| Sep 2024 | - | $13.48M(-57.9%) |
| Jun 2024 | - | $32.06M(+248.1%) |
| Mar 2024 | - | $9.21M(-39.1%) |
| Dec 2023 | $15.12M(-1.9%) | $15.12M(-34.7%) |
| Sep 2023 | - | $23.15M(+71.2%) |
| Jun 2023 | - | $13.52M(-45.8%) |
| Mar 2023 | - | $24.96M(+62.0%) |
| Dec 2022 | $15.41M(-28.4%) | $15.41M(+28.0%) |
| Sep 2022 | - | $12.05M(-47.9%) |
| Jun 2022 | - | $23.11M(+0.9%) |
| Mar 2022 | - | $22.91M(+6.5%) |
| Dec 2021 | $21.51M(+26.1%) | $21.51M(-12.1%) |
| Sep 2021 | - | $24.47M(+77.8%) |
| Jun 2021 | - | $13.76M(-14.6%) |
| Mar 2021 | - | $16.11M(-5.6%) |
| Dec 2020 | $17.06M(-21.4%) | $17.06M(+15.6%) |
| Sep 2020 | - | $14.76M(+3.2%) |
| Jun 2020 | - | $14.31M(-11.9%) |
| Mar 2020 | - | $16.24M(-25.2%) |
| Dec 2019 | $21.72M(+228.8%) | $21.72M(-73.3%) |
| Sep 2019 | - | $81.47M(-3.1%) |
| Jun 2019 | - | $84.12M(+38.8%) |
| Mar 2019 | - | $60.60M(+817.3%) |
| Dec 2018 | $6.61M(-16.0%) | $6.61M(-87.8%) |
| Sep 2018 | - | $54.33M(+30.6%) |
| Jun 2018 | - | $41.61M(-4.7%) |
| Mar 2018 | - | $43.68M(+455.2%) |
| Dec 2017 | $7.87M | $7.87M(-85.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2017 | - | $53.71M(+50.7%) |
| Jun 2017 | - | $35.65M(-10.1%) |
| Mar 2017 | - | $39.65M(+207.2%) |
| Dec 2016 | $12.90M(-21.7%) | $12.90M(-55.5%) |
| Sep 2016 | - | $29.01M(+21.8%) |
| Jun 2016 | - | $23.83M(+5.9%) |
| Mar 2016 | - | $22.50M(+36.6%) |
| Dec 2015 | $16.48M(+180.5%) | $16.48M(-46.1%) |
| Sep 2015 | - | $30.57M(+80.8%) |
| Jun 2015 | - | $16.90M(+6.7%) |
| Mar 2015 | - | $15.83M(+169.5%) |
| Dec 2014 | $5.87M(+173.7%) | $5.87M(-48.2%) |
| Sep 2014 | - | $11.33M(+14.2%) |
| Jun 2014 | - | $9.92M(+8.2%) |
| Mar 2014 | - | $9.17M(+327.2%) |
| Dec 2013 | $2.15M(+1.5%) | $2.15M(-73.7%) |
| Sep 2013 | - | $8.17M(-9.4%) |
| Jun 2013 | - | $9.02M(+40.3%) |
| Mar 2013 | - | $6.43M(+203.9%) |
| Dec 2012 | $2.12M(-17.9%) | $2.12M(-17.9%) |
| Dec 2011 | $2.58M(+386.0%) | $2.58M(-73.7%) |
| Sep 2008 | - | $9.80M(-8.8%) |
| Jun 2008 | - | $10.74M(+923.3%) |
| Mar 2008 | - | $1.05M(+98.1%) |
| Dec 2007 | $530.00K(-55.6%) | $530.00K(-0.9%) |
| Sep 2007 | - | $535.00K(+58.3%) |
| Jun 2007 | - | $338.00K(-80.6%) |
| Mar 2007 | - | $1.74M(+45.4%) |
| Dec 2006 | $1.20M(+31.9%) | $1.20M(+31.9%) |
| Dec 2005 | $906.20K | $906.20K |
FAQ
- What is Amicus Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Amicus Therapeutics?
- What is Amicus Therapeutics annual accounts payable year-on-year change?
- What is Amicus Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Amicus Therapeutics?
- What is Amicus Therapeutics quarterly accounts payable year-on-year change?
What is Amicus Therapeutics annual accounts payable?
The current annual accounts payable of FOLD is $12.95M
What is the all time high annual accounts payable for Amicus Therapeutics?
Amicus Therapeutics all-time high annual accounts payable is $21.72M
What is Amicus Therapeutics annual accounts payable year-on-year change?
Over the past year, FOLD annual accounts payable has changed by -$2.17M (-14.37%)
What is Amicus Therapeutics quarterly accounts payable?
The current quarterly accounts payable of FOLD is $14.45M
What is the all time high quarterly accounts payable for Amicus Therapeutics?
Amicus Therapeutics all-time high quarterly accounts payable is $84.12M
What is Amicus Therapeutics quarterly accounts payable year-on-year change?
Over the past year, FOLD quarterly accounts payable has changed by +$5.24M (+56.91%)